journal article·2024-10-01Open access

Endothelial extracellular vesicles enhance vascular self-assembly in engineered human cardiac tissues

Karl T Wagner, Rick X Z Lu, Shira Landau, Sarah A Shawky, Yimu Zhao, David F Bodenstein, Luis Felipe Jiménez Vargas, Richard Jiang, Sargol Okhovatian, Ying Wang, Chuan Liu, Daniel Vosoughi, Dakota Gustafson, Jason E Fish, Carolyn L Cummins, Milica Radisic

Biofabrication· Volume 16· Issue 4

Abstract

Abstract The fabrication of complex and stable vasculature in engineered cardiac tissues represents a significant hurdle towards building physiologically relevant models of the heart. Here, we implemented a 3D model of cardiac vasculogenesis, incorporating endothelial cells (EC), stromal cells, and human induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CM) in a fibrin hydrogel. The presence of CMs disrupted vessel formation in 3D tissues, resulting in the upregulation of endothelial activation markers and altered extracellular vesicle (EV) signaling in engineered tissues as determined by the proteomic analysis of culture supernatant. miRNA sequencing of CM- and EC-secreted EVs highlighted key EV-miRNAs that were postulated to play differing roles in cardiac vasculogenesis, including the let-7 family and miR-126-3p in EC-EVs. In the absence of CMs, the supplementation of CM-EVs to EC monolayers attenuated EC migration and proliferation and resulted in shorter and more discontinuous self-assembling vessels when applied to 3D vascular tissues. In contrast, supplementation of EC-EVs to the tissue culture media of 3D vascularized cardiac tissues mitigated some of the deleterious effects of CMs on vascular self-assembly, enhancing the average length and continuity of vessel tubes that formed in the presence of CMs. Direct transfection validated the effects of the key EC-EV miRNAs let-7b-5p and miR-126-3p in improving the maintenance of continuous vascular networks. EC-EV supplementation to biofabricated cardiac tissues and microfluidic devices resulted in tissue vascularization, illustrating the use of this approach in the engineering of enhanced, perfusable, microfluidic models of the myocardium.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · Cardiovascular Disease and Adiposity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (80)

Show source-provided references
1. Cardiac tissue vascularization: from angiogenesis to microfluidic blood vessels10.1177/1074248414528576 ↗
2. Organ-level vascularization: the Mars mission of bioengineering10.1016/j.jtcvs.2019.08.128 ↗
3. Vasculature-on-a-chip for in vitro disease models10.3390/bioengineering4010008 ↗
4. Biodegradable scaffold with built-in vasculature for organ-on-a-chip engineering and direct surgical anastomosis10.1038/nmat4570 ↗
5. InVADE: integrated vasculature for assessing dynamic events10.1002/adfm.201703524 ↗
6. A well plate–based multiplexed platform for incorporation of organoids into an organ-on-a-chip system with a perfusable vasculature10.1038/s41596-020-00490-1 ↗
7. IFlowPlate—A customized 384-well plate for the culture of perfusable vascularized colon organoids10.1002/adma.202002974 ↗
8. Capillary diameter and geometry in cardiac and skeletal muscle studied by means of corrosion casts10.1016/0026-2862(83)90044-4 ↗
9. Functional microvascularization of human myocardium in vitro10.1016/j.crmeth.2022.100280 ↗
10. Integrating engineered macro vessels with self-assembled capillaries in 3D implantable tissue for promoting vascular integration in-vivo10.1016/j.biomaterials.2021.121286 ↗
11. Primitive macrophages induce sarcomeric maturation and functional enhancement of developing human cardiac microtissues via efferocytic pathways10.1038/s44161-024-00471-7 ↗
12. A new role for extracellular vesicles in cardiac tissue engineering and regenerative medicine10.1002/anbr.202100047 ↗
13. Extracellular vesicles in cardiac regeneration: potential applications for tissues-on-a-chip10.1016/j.tibtech.2020.08.005 ↗
14. Co-culture systems for vasculogenesis
15. Localization of engineered vasculature within 3D tissue constructs10.3389/fbioe.2018.00002 ↗
16. Prevascularized scaffolds bearing human dental pulp stem cells for treating complete spinal cord injury10.1002/adhm.202000974 ↗
17. Primitive macrophages enable long-term vascularization of human heart-on-chip platforms10.1016/j.stem.2024.05.011 ↗
18. Vascular cells improve functionality of human cardiac organoids10.1016/j.celrep.2023.112322 ↗
19. Insight on oxygen-supplying biomaterials used to enhance cell survival, retention, and engraftment for tissue repair10.3390/biomedicines11061592 ↗
20. Limitations of oxygen delivery to cells in culture: an underappreciated problem in basic and translational research10.1016/j.freeradbiomed.2017.10.003 ↗
21. Linking endothelial dysfunction with endothelial cell activation10.1172/JCI66843 ↗
22. Endothelial cell activation. A central pathophysiological process10.1136/bmj.316.7141.1328 ↗
23. Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP10.1073/pnas.1714446115 ↗
24. Anti-angiogenic targets: angiopoietin and angiopoietin receptors
25. PI3K/AKT/mTOR pathway in angiogenesis10.3389/fnmol.2011.00051 ↗
26. The insulin-like growth factor signalling pathway in cardiac development and regeneration10.3390/ijms23010234 ↗
27. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines10.1080/20013078.2018.1535750 ↗
28. Cardiac tissue model of immune-induced dysfunction reveals the role of free mitochondrial DNA and the therapeutic effects of exosomes10.1126/sciadv.adk0164 ↗
29. Cardiac recovery via extended cell-free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells10.1038/s41551-018-0229-7 ↗
30. A comparison of cellular uptake mechanisms, delivery efficacy, and intracellular fate between liposomes and extracellular vesicles10.1002/adhm.202300319 ↗
31. On-chip human microvasculature assay for visualization and quantification of tumor cell extravasation dynamics10.1038/nprot.2017.018 ↗
32. Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells10.1016/j.yjmcc.2014.05.001 ↗
33. Exosomes secreted by cardiomyocytes subjected to ischaemia promote cardiac angiogenesis10.1093/cvr/cvx118 ↗
34. Extracellular vesicles released by human induced-pluripotent stem cell-derived cardiomyocytes promote angiogenesis10.3389/fphys.2018.01794 ↗
35. Endothelial-cardiomyocyte interactions in cardiac development and repair10.1146/annurev.physiol.68.040104.124629 ↗
36. Cardiomyocyte—endothelial cell interactions in cardiac remodeling and regeneration10.3389/fcvm.2018.00101 ↗
37. Coculture of endothelial cells with human pluripotent stem cell-derived cardiac progenitors reveals a differentiation stage-specific enhancement of cardiomyocyte maturation10.1002/biot.201800725 ↗
38. Extracellular vesicles in angiogenesis10.1161/CIRCRESAHA.117.309681 ↗
39. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells10.1016/S0002-9440(10)64887-0 ↗
40. Extracellular Vesicles’ role in angiogenesis and altering angiogenic signaling10.3390/medsci12010004 ↗
41. New mechanism for Notch signaling to endothelium at a distance by delta-like 4 incorporation into exosomes10.1182/blood-2009-08-239228 ↗
42. Activated Stat5 trafficking via endothelial cell-derived extracellular vesicles controls IL-3 pro-angiogenic paracrine action10.1038/srep25689 ↗
43. Extracellular vesicles mediate communication between endothelial and vascular smooth muscle cells10.3390/ijms23010331 ↗
44. Endothelial extracellular vesicles contain protective proteins and rescue ischemia-reperfusion injury in a human heart-on-chip10.1126/scitranslmed.aax8005 ↗
45. Let-7 micrornas: their role in cerebral and cardiovascular diseases, inflammation, cancer, and their regulation10.3390/biomedicines9060606 ↗
46. Endothelial cell-derived extracellular vesicles impair the angiogenic response of coronary artery endothelial cells10.3389/fcvm.2022.923081 ↗
47. Let-7e modulates the inflammatory response in vascular endothelial cells through ceRNA crosstalk10.1038/s41598-016-0028-x ↗
48. MicroRNA let-7a regulates angiogenesis by targeting TGFBR3 mRNA10.1111/jcmm.13960 ↗
49. Bioinspired artificial exosomes based on lipid nanoparticles carrying let-7b-5p promote angiogenesis in vitro and in vivo10.1016/j.ymthe.2021.03.015 ↗
50. A review on angiogenesis and its assays10.22038/ijbms.2012.4929 ↗
51. A regulatory microRNA network controls endothelial cell phenotypic switch during sprouting angiogenesis10.7554/eLife.48095 ↗
52. TGF-β signaling in vascular biology and dysfunction10.1038/cr.2008.326 ↗
53. Role of matrix metalloproteinases in angiogenesis and cancer10.3389/fonc.2019.01370 ↗
54. Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) signaling in angiogenesis: a crucial target for anti- and pro-angiogenic therapies10.1177/1947601911423031 ↗
55. VEGF gene therapy: stimulating angiogenesis or angioma-genesis?10.1038/80430 ↗
56. Building better vasculature10.1101/gad.931601 ↗
57. Complementary actions of VEGF and Angiopoietin-1 on blood vessel growth and leakage10.1046/j.1469-7580.2002.00061.x ↗
58. Biological properties of extracellular vesicles and their physiological functions10.3402/jev.v4.27066 ↗
59. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions10.1038/nprot.2012.150 ↗
60. NIH Image to ImageJ: 25 years of image analysis10.1038/nmeth.2089 ↗
61. A computational tool for quantitative analysis of vascular networks10.1371/journal.pone.0027385 ↗
62. FlowJoTM Software (for Mac) [software application] Version 10.10
63. Vasculature-on-a-chip platform with innate immunity enables identification of angiopoietin-1 derived peptide as a therapeutic for SARS-CoV-2 induced inflammation10.1039/D1LC00817J ↗
64. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics10.1038/nprot.2016.136 ↗
65. The Perseus computational platform for comprehensive analysis of (prote)omics data10.1038/nmeth.3901 ↗
66. Cytoscape StringApp: network analysis and visualization of proteomics data10.1021/acs.jproteome.8b00702 ↗
67. PANTHER: making genome-scale phylogenetics accessible to all10.1002/pro.4218 ↗
68. Protocol Update for large-scale genome and gene function analysis with the PANTHER classification system (v.14.0)10.1038/s41596-019-0128-8 ↗
69. The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences10.1093/nar/gkab1038 ↗
70. ExtraPEG: a polyethylene glycol-based method for enrichment of extracellular vesicles10.1038/srep23978 ↗
71. PCAGO: an interactive tool to analyze RNA-Seq data with principal component analysis10.1101/433078 ↗
72. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq210.1186/s13059-014-0550-8 ↗
73. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2022 update10.1093/nar/gkac247 ↗
74. DIANA-miRPath v3.0: deciphering microRNA function with experimental support10.1093/nar/gkv403 ↗
75. MiRDB: an online database for prediction of functional microRNA targets10.1093/nar/gkz757 ↗
76. Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data10.1186/s13059-019-1629-z ↗
77. An image J plugin for the high throughput image analysis of in vitro scratch wound healing assays10.1371/journal.pone.0232565 ↗
78. Confounding factors in vesicle uptake studies using fluorescent lipophilic membrane dyes10.1080/20013078.2017.1388731 ↗
79. Mir-126-3p is dynamically regulated in endothelial-to-mesenchymal transition during fibrosis10.3390/ijms22168629 ↗
80. Microfabrication of AngioChip, a biodegradable polymer scaffold with microfluidic vasculature10.1038/s41596-018-0015-8 ↗